Evidence map›Paper›PMID 41704751›Full record

ArticleiScience2026

Integrating thermal liquid biopsy, clinical data, and mass spectrometry for early diagnosis and biomarker discovery in colorectal cancer.

Sonia Hermoso-Durán, David Ortega-Alarcon, Astrid Z Johansen, Mattew J McKay, Julia S Johansen, Sonia Vega, Claus L Feltoft, Troels Gammeltoft Dolin, Jakob Lykke, Nicolas Fraunhoffer and 6 more

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sonia Hermoso-DuránInstitute of Biocomputation and Physics of Complex Systems (BIFI), Universidad de Zaragoza, Zaragoza 50018, Spain.
David Ortega-AlarconInstitute of Biocomputation and Physics of Complex Systems (BIFI), Universidad de Zaragoza, Zaragoza 50018, Spain.
Astrid Z JohansenDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, 2730 Herlev, Denmark.
Mattew J McKaySchool of Medical Sciences, Kolling Institute, The University of Sydney, St Leonards, NSW, Australia.
Julia S JohansenDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, 2730 Herlev, Denmark.
Sonia VegaInstitute of Biocomputation and Physics of Complex Systems (BIFI), Universidad de Zaragoza, Zaragoza 50018, Spain.
Claus L FeltoftDepartment of Medicine, Copenhagen University Hospital - Herlev and Gentofte, 2730 Herlev, Denmark.
Troels Gammeltoft DolinDepartment of Medicine, Copenhagen University Hospital - Herlev and Gentofte, 2730 Herlev, Denmark.
Jakob LykkeDepartment of Surgery, Copenhagen University Hospital - Herlev and Gentofte, 2730 Herlev, Denmark.
Nicolas FraunhofferAix-Marseille Université, CNRS, Equipe labélisée Ligue Nationale Contre le Cancer, Centre Interdisciplinaire de Nanoscience de Marseille, 13288 Marseille, France.
Oscar Sanchez-GraciaDepartamento de Ingeniería Electrónica y Comunicaciones, Universidad de Zaragoza, Zaragoza 50009, Spain.
Pablo F GarridoInstitute of Biocomputation and Physics of Complex Systems (BIFI), Universidad de Zaragoza, Zaragoza 50018, Spain.
Ángel LanasInstituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza 50009, Spain.
Mark P MolloySchool of Medical Sciences, Kolling Institute, The University of Sydney, St Leonards, NSW, Australia.
Adrian Velazquez-CampoyInstitute of Biocomputation and Physics of Complex Systems (BIFI), Universidad de Zaragoza, Zaragoza 50018, Spain.
Olga AbianInstitute of Biocomputation and Physics of Complex Systems (BIFI), Universidad de Zaragoza, Zaragoza 50018, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early detection of colorectal cancer is essential to improving survival, where yet current diagnostic tools show limited performance. This study aimed to enhance diagnostic accuracy by integrating clinical variables with thermogram profiles obtained through serum-based thermal liquid biopsy and analyzed using machine learning models. We evaluated 328 patients with colorectal cancer and 355 symptomatic individuals with non-organ-specific cancer signs but negative diagnostic evaluations, to reproduce clinically relevant decision settings. The combined model showed improved classification performance compared with the use of clinical variables alone, particularly in patients with early-stage disease. In addition, proteomic analysis of samples stratified by thermogram patterns identified proteins associated with survival, including fibrinogen-like protein 1, supporting the biological relevance of these thermodynamic profiles. Together, these findings indicate that integrating serum thermogram information with routine clinical data can modestly strengthen diagnostic assessment and help identify biologically meaningful patient subgroups, offering a promising non-invasive colorectal cancer evaluation.

Indexed as

health technologymedical specialtymedical testsprocedureprocess

Identifiers

PMID41704751
PMCPMC12907641

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.